These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 9891525)
21. Local recurrence of breast cancer demonstrated on 99mTc-MIBI scintigraphy. Katayama N; Inoue Y; Ichikawa T; Harada M; Itoh T; Shimoyamada K; Ikeda M; Tsukune Y; Yoshikawa K Radiat Med; 1999; 17(5):389-91. PubMed ID: 10593293 [TBL] [Abstract][Full Text] [Related]
22. Abundant blood supply and low P-glycoprotein expression on dynamic 99mTc-MIBI imaging predicted better chemotherapy sensitivity for a breast cancer patient: a case report. Si H; Li X J Nucl Med Technol; 2012 Jun; 40(2):89-91. PubMed ID: 22505488 [TBL] [Abstract][Full Text] [Related]
23. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. Del Vecchio S; Ciarmiello A; Pace L; Potena MI; Carriero MV; Mainolfi C; Thomas R; D'Aiuto G; Tsuruo T; Salvatore M J Nucl Med; 1997 Sep; 38(9):1348-51. PubMed ID: 9293785 [TBL] [Abstract][Full Text] [Related]
24. Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models. Ohira H; Kubota K; Ohuchi N; Harada Y; Fukuda H; Satomi S J Nucl Med; 2000 Sep; 41(9):1561-8. PubMed ID: 10994739 [TBL] [Abstract][Full Text] [Related]
25. Experimental and clinical observations of 99mTc-MIBI uptake correlate with P-glycoprotein expression in lung cancer. Yang A; Xue J; Li X; Yu Y; Deng H; Hu G; Meng X; Li J Nucl Med Commun; 2007 Sep; 28(9):696-703. PubMed ID: 17667748 [TBL] [Abstract][Full Text] [Related]
26. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings]. Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292 [TBL] [Abstract][Full Text] [Related]
27. 99mTc-MIBI in the evaluation of breast cancer biology. Del Vecchio S; Salvatore M Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S88-96. PubMed ID: 15105972 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Effect of Resveratrol and Doxorubicin on Hallajian F; Ghasmi M; Abedi SM; Behzadi R; Hayati E; Sadeghzadeh N; Rezazadeh F; Karimi H Cancer Biother Radiopharm; 2018 Nov; 33(9):403-410. PubMed ID: 30040447 [TBL] [Abstract][Full Text] [Related]
29. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. Cutrone JA; Yospur LS; Khalkhali I; Tolmos J; Devito A; Diggles L; Vargas MP; Shitabata P; French S J Nucl Med; 1998 Mar; 39(3):449-53. PubMed ID: 9529290 [TBL] [Abstract][Full Text] [Related]
30. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells. Kinuya S; Bai J; Shiba K; Yokoyama K; Mori H; Fukuoka M; Watanabe N; Shuke N; Michigishi T; Tonami N Ann Nucl Med; 2006 Jan; 20(1):29-34. PubMed ID: 16485571 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of clinical utility of 99mTc-MIBI scintigraphy in the localization of thyroid, breast and lung/mediastinum tumors--a report of multicenter phase III clinical trials]. Kubo A; Enomoto K; Kusakabe K; Fukumitsu N; Takami H; Oshima M; Aburano T; Endo K; Tonami N; Konishi J; Nishimura T; Narabayashi I; Masuda K Kaku Igaku; 1998 Nov; 35(9):909-28. PubMed ID: 9916408 [TBL] [Abstract][Full Text] [Related]
32. 99mTc-MIBI scan in mammary Pagets disease: a case report. Han S; Kim JS; Kim BS; Koh IH; Park K J Korean Med Sci; 1999 Dec; 14(6):675-8. PubMed ID: 10642948 [TBL] [Abstract][Full Text] [Related]
33. [The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer]. Qu X; Wang Y; Chen D; Li C Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):41-3. PubMed ID: 11829776 [TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer. Nishiyama Y; Kawasaki Y; Yamamoto Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Tanabe M J Nucl Med; 1997 Sep; 38(9):1358-61. PubMed ID: 9293787 [TBL] [Abstract][Full Text] [Related]
35. Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. Luker GD; Fracasso PM; Dobkin J; Piwnica-Worms D J Nucl Med; 1997 Mar; 38(3):369-72. PubMed ID: 9074520 [TBL] [Abstract][Full Text] [Related]
36. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases]. Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570 [TBL] [Abstract][Full Text] [Related]
37. [Differentiation of benign and malignant palpable breast masses using 99mTc-MIBI imaging]. He J; Li Y; Su J Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):226-8. PubMed ID: 9868120 [TBL] [Abstract][Full Text] [Related]
39. [Correlation between accumulation of (99m)Tc-MIBI in breast cancer or benign lesion, cell proliferation and angiogenesis]. Chen J; Yin Y; Chen S Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):553-5. PubMed ID: 11825464 [TBL] [Abstract][Full Text] [Related]
40. Wash-out kinetics of 99mTc-MIBI and the scintigraphic determination of Pgp expression: reply. Del Vecchio S; Ciarmiello A; Salvatore M Eur J Nucl Med; 1998 Feb; 25(2):192. PubMed ID: 9537801 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]